Redwood City, California-based Genomic Health, Inc. is considering an initial public offering (IPO) to raise as much as $75 million. The company filed preliminary documents with the Securities and Exchange Commission (SEC) on July 15, 2005. In January 2004, Genomic Health launched OncoType D™ for early-stage breast cancer patients. The company is assembling clinical data …
“August 1, 2005 Intelligence: Late Breaking Lab News” Read More »
